Follow
Luc Dirix
Luc Dirix
Unknown affiliation
Verified email at telenet.be
Title
Cited by
Cited by
Year
Landscape of somatic mutations in 560 breast cancer whole-genome sequences
S Nik-Zainal, H Davies, J Staaf, M Ramakrishna, D Glodzik, X Zou, ...
Nature 534 (7605), 47-54, 2016
21492016
Efficacy and safety of vismodegib in advanced basal-cell carcinoma
A Sekulic, MR Migden, AE Oro, L Dirix, KD Lewis, JD Hainsworth, ...
New England Journal of Medicine 366 (23), 2171-2179, 2012
16102012
Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial
RL Coleman, AM Oza, D Lorusso, C Aghajanian, A Oaknin, A Dean, ...
The Lancet 390 (10106), 1949-1961, 2017
15682017
Phase III study of bevacizumab plus docetaxel compared with placebo plus docetaxel for the first-line treatment of human epidermal growth factor receptor 2–negative metastatic …
DW Miles, A Chan, LY Dirix, J Cortés, X Pivot, P Tomczak, T Delozier, ...
Journal of clinical oncology 28 (20), 3239-3247, 2010
10712010
Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation
PB Vermeulen, G Gasparini, SB Fox, M Toi, L Martin, P McCulloch, ...
European Journal of Cancer 32 (14), 2474-2484, 1996
9321996
Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data
FC Bidard, DJ Peeters, T Fehm, F Nolé, R Gisbert-Criado, D Mavroudis, ...
The lancet oncology 15 (4), 406-414, 2014
9182014
Exemestane is superior to megestrol acetate after tamoxifen failure in postmenopausal women with advanced breast cancer: results of a phase III randomized double-blind trial
M Kaufmann, E Bajetta, LY Dirix, LE Fein, SE Jones, N Zilembo, ...
Journal of Clinical Oncology 18 (7), 1399-1411, 2000
6882000
Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study
LY Dirix, I Takacs, G Jerusalem, P Nikolinakos, HT Arkenau, ...
Breast cancer research and treatment 167, 671-686, 2018
6792018
Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours
PB Vermeulen, G Gasparini, SB Fox, C Colpaert, LP Marson, M Gion, ...
European journal of cancer 38 (12), 1564-1579, 2002
6302002
Neratinib, an irreversible ErbB receptor tyrosine kinase inhibitor, in patients with advanced ErbB2-positive breast cancer
HJ Burstein, Y Sun, LY Dirix, Z Jiang, R Paridaens, AR Tan, A Awada, ...
J Clin Oncol 28 (8), 1301-1307, 2010
6292010
Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trial
MR Patel, J Ellerton, JR Infante, M Agrawal, M Gordon, R Aljumaily, ...
The Lancet Oncology 19 (1), 51-64, 2018
5842018
Circulating interleukin‐6 predicts survival in patients with metastatic breast cancer
R Salgado, S Junius, I Benoy, P Van Dam, P Vermeulen, E Van Marck, ...
International journal of cancer 103 (5), 642-646, 2003
5832003
Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel
M Aapro, PA Abrahamsson, JJ Body, RE Coleman, R Colomer, L Costa, ...
Annals of oncology 19 (3), 420-432, 2008
5762008
International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment
S Dawood, SD Merajver, P Viens, PB Vermeulen, SM Swain, TA Buchholz, ...
Annals of oncology 22 (3), 515-523, 2011
5432011
Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind …
SB Kim, R Dent, SA Im, M Espié, S Blau, AR Tan, SJ Isakoff, M Oliveira, ...
The Lancet Oncology 18 (10), 1360-1372, 2017
4822017
Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse
M Brada, K Hoang-Xuan, R Rampling, PY Dietrich, LY Dirix, D Macdonald, ...
Annals of Oncology 12 (2), 259-266, 2001
4812001
Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial
MR Migden, A Guminski, R Gutzmer, L Dirix, KD Lewis, P Combemale, ...
The Lancet Oncology 16 (6), 716-728, 2015
4402015
Phase II randomized study of trastuzumab emtansine versus trastuzumab plus docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer
SA Hurvitz, L Dirix, J Kocsis, GV Bianchi, J Lu, J Vinholes, E Guardino, ...
J Clin Oncol 31 (9), 1157-1163, 2013
4322013
Vascular integrin alpha (v) beta3: a new prognostic indicator in breast cancer.
G Gasparini, PC Brooks, E Biganzoli, PB Vermeulen, E Bonoldi, LY Dirix, ...
Clinical cancer research: an official journal of the American Association …, 1998
4271998
Capecitabine, an oral fluoropyrimidine carbamate with substantial activity in advanced colorectal cancer: results of a randomized phase II study
E Van Cutsem, M Findlay, B Osterwalder, W Kocha, D Dalley, R Pazdur, ...
Journal of Clinical Oncology 18 (6), 1337-1345, 2000
4202000
The system can't perform the operation now. Try again later.
Articles 1–20